NDC 0006-3516

PRIMAXIN IV

Imipenem And Cilastatin Sodium

PRIMAXIN IV is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Imipenem; Cilastatin Sodium.

Product ID0006-3516_25896be0-b49d-43cd-8f90-105327b2ecfe
NDC0006-3516
Product TypeHuman Prescription Drug
Proprietary NamePRIMAXIN IV
Generic NameImipenem And Cilastatin Sodium
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1985-11-26
Marketing CategoryNDA / NDA
Application NumberNDA050587
Labeler NameMerck Sharp & Dohme Corp.
Substance NameIMIPENEM; CILASTATIN SODIUM
Active Ingredient Strength500 mg/100mL; mg/100mL
Pharm ClassesCarbapenems [CS],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0006-3516-59

25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) > 100 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date1985-11-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0006-3516-59 [00006351659]

PRIMAXIN IV INJECTION, POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA050587
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1985-11-26

Drug Details

Active Ingredients

IngredientStrength
IMIPENEM500 mg/100mL

OpenFDA Data

SPL SET ID:f41d8abd-7792-4918-1b93-bd83ea01955e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1726216
  • 1726214
  • 1726204
  • 1726207
  • Pharmacological Class

    • Carbapenems [CS]
    • Penem Antibacterial [EPC]
    • Dipeptidase Inhibitors [MoA]
    • Renal Dehydropeptidase Inhibitor [EPC]

    NDC Crossover Matching brand name "PRIMAXIN IV" or generic name "Imipenem And Cilastatin Sodium"

    NDCBrand NameGeneric Name
    63323-322Imipenem and CilastatinImipenem and Cilastatin Sodium
    63323-349Imipenem and CilastatinImipenem and Cilastatin Sodium
    0006-3516PRIMAXINimipenem and cilastatin sodium

    Trademark Results [PRIMAXIN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PRIMAXIN
    PRIMAXIN
    73446124 1297360 Live/Registered
    Merck & Co., Inc.
    1983-09-30

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.